Patents by Inventor Paul Hanavan

Paul Hanavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210137883
    Abstract: Compounds and methods involving inhibition of the enzymatic activity of QSOX1. The compounds and methods can be used in treatment of neoplastic cells, for example, to suppress tumor growth and invasion in a variety of cancers, including but not limited to myeloma and cancers of the breast, kidney, and pancreas.
    Type: Application
    Filed: December 16, 2020
    Publication date: May 13, 2021
    Inventors: Douglas Lake, Erik Castle, Paul Hanavan, Douglas Faigel, Thai Ho
  • Patent number: 10894034
    Abstract: Compounds and methods involving inhibition of the enzymatic activity of QSOX1 (FIG. 13). The compounds and methods can be used in treatment of neoplastic cells, for example, to suppress tumor growth and invasion in a variety of cancers, including but not limited to myeloma and cancers of the breast, kidney, and pancreas.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: January 19, 2021
    Assignees: Arizona Board of Regents on behalf of Arizona State University, Mayo Foundation for Medical Education and Research
    Inventors: Douglas Lake, Erik Castle, Paul Hanavan, Douglas Faigel, Thai Ho
  • Publication number: 20190008829
    Abstract: Compounds and methods involving inhibition of the enzymatic activity of QSOX1 (FIG. 13). The compounds and methods can be used in treatment of neoplastic cells, for example, to suppress tumor growth and invasion in a variety of cancers, including but not limited to myeloma and cancers of the breast, kidney, and pancreas.
    Type: Application
    Filed: September 13, 2016
    Publication date: January 10, 2019
    Inventors: Douglas Lake, Erik Castle, Paul Hanavan, Douglas Faigel, Thai Ho